Lemonade Inc. (LMND)
Lemonade Stock Outpaces Industry, Trades at a Premium: Should You Buy?
LMND leverages AI and multi-product expansion to drive accelerating premium growth and targets $1.19B revenues by 2026, but profitability remains out of reach.
Is Lemonade a Buy After Morgan Stanley's Upgrade?
In January, Lemonade debuted an autonomous car insurance product. Last week, Morgan Stanley boosted its price target on Lemonade from $80 to $85, in part due to the promise of that new offering.
Lemonade (LMND) Soars 15.8%: Is Further Upside Left in the Stock?
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
This Bull Signal Has Never Failed Lemonade Stock
Lemonade Inc (NYSE:LMND) stock is down 1.2% to trade at $49.89 at last glance, on track for its fourth-straight loss after yesterday recording its worst single-day percentage drop since April.
Lemonade: AI Is A Net Tailwind As 2027 Profitability Remains In Sight
Lemonade remains a compelling "Buy" as AI enhances, not disrupts, its digital insurance platform. LMND's Pet insurance segment, now its second-largest, is growing over 50% y/y and benefits from AI-driven claims automation. AI adoption has reduced Pet claims processing costs by 26% y/y and enabled IFP to double while opex and headcount remain flat or decline.
LMND Q4 Loss Narrower Than Expected on Solid Underwriting
LMND narrows Q4 loss, beats revenue estimates with 53% growth, rising premiums and stronger margins, while boosting its 2026 outlook.
Lemonade's Sweet Results Refresh Market Appetite: Rebound Ahead
Lemonade's NYSE: LMND sweet Q4 2026 results triggered a floor in the stock's price action, indicating a high potential for it to rebound and set a fresh long-term high. The results were blowout, affirming the company's flywheel is gaining momentum.
Lemonade, Inc. (LMND) Q4 2025 Earnings Call Transcript
Lemonade, Inc. (LMND) Q4 2025 Earnings Call Transcript
Lemonade (LMND) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Lemonade (LMND) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Lemonade (LMND) Reports Q4 Loss, Tops Revenue Estimates
Lemonade (LMND) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.42 per share a year ago.
Will Lemonade Stock Enjoy Another Major Post-Earnings Win?
Health insurance company Lemonade Inc (NYSE:LMND) is gearing up for its fourth-quarter report, due out before the open on Thursday, Feb. 19.
Lemonade Gears Up to Report Q4 Earnings: Here's What to Expect
LMND Q4 earnings are likely to have gained from higher premiums per customer, expansion of geographic footprint, product offerings and an expanding customer base.
